Hyperprolactinemia
"Hyperprolactinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
Descriptor ID |
D006966
|
MeSH Number(s) |
C10.228.140.617.738.250.450 C19.700.355.600
|
Concept/Terms |
Hyperprolactinemia- Hyperprolactinemia
- Hyperprolactinemias
- Prolactin, Inappropriate Secretion
- Inappropriate Secretion Prolactin
- Secretion Prolactin, Inappropriate
- Inappropriate Prolactin Secretion Syndrome
- Prolactin Hypersecretion Syndrome
- Hypersecretion Syndrome, Prolactin
- Syndrome, Prolactin Hypersecretion
- Hyperprolactinaemia
- Inappropriate Prolactin Secretion
- Prolactin Secretion, Inappropriate
- Secretion, Inappropriate Prolactin
|
Below are MeSH descriptors whose meaning is more general than "Hyperprolactinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperprolactinemia".
This graph shows the total number of publications written about "Hyperprolactinemia" by people in this website by year, and whether "Hyperprolactinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperprolactinemia" by people in Profiles.
-
Kanu AA, Johnston MM, Poweleit EA, Vaughn SE, Strawn JR, Ramsey LB. Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents. J Child Adolesc Psychopharmacol. 2024 02; 34(1):34-41.